169 related articles for article (PubMed ID: 34762897)
21. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells.
Tian T; Guo T; Zhen W; Zou J; Li F
Cell Death Dis; 2020 Oct; 11(10):900. PubMed ID: 33093476
[TBL] [Abstract][Full Text] [Related]
22. Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.
Bhuvanalakshmi G; Gamit N; Patil M; Arfuso F; Sethi G; Dharmarajan A; Kumar AP; Warrier S
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30591679
[TBL] [Abstract][Full Text] [Related]
23. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
[TBL] [Abstract][Full Text] [Related]
24. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
[TBL] [Abstract][Full Text] [Related]
25. Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.
Perumal V; Arfuso F; Chen Y; Fox S; Dharmarajan AM
Mol Cell Biochem; 2018 Jun; 443(1-2):205-213. PubMed ID: 29185158
[TBL] [Abstract][Full Text] [Related]
26. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
27. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
[TBL] [Abstract][Full Text] [Related]
30. Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2.
Kamino M; Kishida M; Kibe T; Ikoma K; Iijima M; Hirano H; Tokudome M; Chen L; Koriyama C; Yamada K; Arita K; Kishida S
Cancer Sci; 2011 Mar; 102(3):540-8. PubMed ID: 21205070
[TBL] [Abstract][Full Text] [Related]
31. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
32. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
33. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
34. Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/β-catenin signaling pathway.
Hu T; Xie N; Qin C; Wang J; You Y
Tumour Biol; 2015 Dec; 36(12):9357-64. PubMed ID: 26108996
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
[TBL] [Abstract][Full Text] [Related]
36. Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells.
Yue X; Lan F; Yang W; Yang Y; Han L; Zhang A; Liu J; Zeng H; Jiang T; Pu P; Kang C
Brain Res; 2010 Dec; 1366():27-37. PubMed ID: 20969832
[TBL] [Abstract][Full Text] [Related]
37. Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/β-Catenin Pathway.
Wang Y; Yang Q; Cheng Y; Gao M; Kuang L; Wang C
Med Sci Monit; 2018 Dec; 24():9110-9119. PubMed ID: 30552850
[TBL] [Abstract][Full Text] [Related]
38. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.
Vaid M; Prasad R; Sun Q; Katiyar SK
PLoS One; 2011; 6(7):e23000. PubMed ID: 21829575
[TBL] [Abstract][Full Text] [Related]
39.
Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
[No Abstract] [Full Text] [Related]
40. Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.
Song W; Zhao H; Cui Z; Ma X; Zhang W; Wang D; Liu A; Yuan L
Tumour Biol; 2016 Nov; 37(11):15229-15240. PubMed ID: 27686608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
